Salvatore Rizza Selected Research

Neoplasms (Cancer)

1/2023	GSNOR deficiency promotes tumor growth via FAK1 S-nitrosylation.
1/2022	Lamin A/C impairments cause mitochondrial dysfunction by attenuating PGC1α and the NAMPT-NAD+ pathway.
1/2022	Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780).
1/2021	AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity.
1/2021	Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma.
10/2020	Exploiting S-nitrosylation for cancer therapy: facts and perspectives.
1/2020	Mitophagy contributes to alpha-tocopheryl succinate toxicity in GSNOR-deficient hepatocellular carcinoma.
1/2020	When S-Nitrosylation Gets to Mitochondria: From Signaling to Age-Related Diseases.
1/2016	Tumor Suppressor Roles of the Denitrosylase GSNOR.
1/2016	S-nitrosylation of the Mitochondrial Chaperone TRAP1 Sensitizes Hepatocellular Carcinoma Cells to Inhibitors of Succinate Dehydrogenase.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salvatore Rizza Research Topics

Disease

12	Neoplasms (Cancer) 01/2023 - 01/2012
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2016
2	Carcinogenesis 01/2016 - 01/2012
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Progeria (Hutchinson Gilford Syndrome) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Premature Aging 01/2022
1	Laminopathies 01/2022
1	Genomic Instability 01/2021
1	Ischemia 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2015
1	Hypoxia (Hypoxemia) 01/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Atrophy 08/2014

Drug/Important Bio-Agent (IBA)

4	EnzymesIBA 01/2023 - 01/2015
4	glutathione-independent formaldehyde dehydrogenase (formaldehyde dehydrogenase)IBA 01/2023 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 08/2014
2	Focal Adhesion Kinase 1IBA 01/2023 - 01/2021
2	Succinic Acid (Succinate)IBA 01/2020 - 01/2016
2	S-NitrosothiolsIBA 08/2014 - 01/2012
1	ElementsIBA 01/2023
1	SuspensionsIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Auranofin (Ridaura)FDA Link 01/2022
1	ChromatinIBA 01/2022
1	ProteomeIBA 01/2022
1	Lamin Type A (Lamin A)IBA 01/2022
1	PhytochemicalsIBA 01/2021
1	VemurafenibIBA 01/2021
1	Retinoblastoma ProteinIBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	Cyclin DIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 10/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2016
1	Protein SIBA 01/2016
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2016
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2015
1	Tyrosine (L-Tyrosine)FDA Link 08/2014
1	Glutamine (L-Glutamine)FDA Link 09/2012
1	Pyruvic Acid (Pyruvate)IBA 09/2012
1	bromopyruvateIBA 09/2012

Therapy/Procedure

2	Therapeutics 01/2021 - 10/2020
1	Drug Therapy (Chemotherapy) 09/2012